The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Changes in glucose, insulin, and insulin resistance from presurgery to post adjuvant treatment for breast cancer.
Emer M. Guinan
No relevant relationships to disclose
Juliette M. Hussey
No relevant relationships to disclose
Laura Healy
No relevant relationships to disclose
Paul A. Carroll
No relevant relationships to disclose
John Kennedy
No relevant relationships to disclose
E. M. Connolly
No relevant relationships to disclose